Jobs / United States / Regeneron Pharmaceuticals INC
Summer 2027 MBA Interns | Business Leadership Development Program (BuiLD)
Regeneron Pharmaceuticals INC · 🇺🇸 2 Locations
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 290 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 40 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Regeneron Pharmaceuticals INC paid sponsored hires in similar roles1 certified filing for “Business Leadership Development (Build) Associate” (Market Research Analysts and Marketing Specialists) in NY: $163k–$163k, median $163k. Most were filed at wage level III (100%) — 3 lottery entries, ≈46% projected selection odds for cap-subject employers. The pay stated here ($70.40/hr) is below what this employer usually pays sponsored hires for this role. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Regeneron Pharmaceuticals INC
The US Department of Labor certified 290 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 40 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Regeneron Pharmaceuticals INC →
About the role
Tarrytown is where medicines are discovered. Our robust research and development engine allows us to discover therapies that could have a profound impact on patient health and scientific outcomes. We generate ideas, explore them, and challenge them on their way to becoming life-changing medicines. Our unique ability to repeatedly and consistently translate science into medicine has led to a robust pipeline of clinical-stage medicines, all of which were discovered in our laboratories. Our investigational treatments target allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, neuromuscular diseases, infectious diseases, and rare diseases. It’s a collegial place where science leads, and you’ll be supplied with what you need to do great work. We’re creative thinkers and rigorous workers. We never lose sight of the fact that the work we do here can change the world. We are seeking 1st Year MBA students who are passionate about science and the business of biotechnology to join Regeneron’s MBA Summer internship program. Opportunities are available in the following areas: • Corporate Strategy • Business Development • Market Access Strategy • New Products • Rare Disease Marketing In this role, a typical internship experience might include the following: • Working on meaningful, high-impact projects • Gaining exposure to senior leadership through Lunch & Learns and other events • Presenting a final project to senior leaders including the BuiLD board • Participating in team building and other fun events with the BuiLD community • Experiencing Regeneron’s amazing culture firsthand • Collaborating, learning, and growing from a world-class organization This role might be for you if: • You are a self-starter with an entrepreneurial spirit • You are passionate about Regeneron’s mission of science to medicine • You can execute in a cross-functional environment • You possess strong project management skills • You have proven leadership skills in previous roles • You have strong problem-solving skills with the ability to think through complex business problems and propose a path toward arriving at a solution • You have integrity and a dedication to high ethical standards To be considered for this opportunity, you must be enrolled in a distinguished MBA program, anticipating graduating in the Spring/Summer of 2028. Experience in biotech, biotech consulting, or biotech investing is preferred. When applying, please include a resume and cover letter indicating which business area you are interested in applying (you may apply to more than one). Applications accepted: October 1, 2026 – December 3, 2026. Pay Rate for MBA Summer Interns is $70.40/hr. Does this sound like you? Apply now to take your first step towards living the Regeneron Way! We are committed to building a workplace with an inclusive culture. Regeneron is an equal opportunity employer and all qualified applicants will receive consideration for employment without regard to race, color, religion or belief (or lack thereof), sex, sexual orientation, gender identity or expression, gender reassignment, marital or civil partnership status, civil status, pregnancy or parental status, age, disability, nationality, citizenship status, ethnic or national origin, membership of the Traveler community, familial status, genetic information, military or veteran status, or any other characteristic protected under applicable law. Where required, we will provide reasonable accommodation to applicants with known disabilities or chronic illnesses during the recruitment process, unless such accommodation would impose undue hardship. Where necessary, we disclose salary ranges for roles in all countries in which we operate. The final offer will